CEO SUMMARY: How is it that some commercial payers for one lab running molecular tests have continued to pay the lab for tests it has run this year, but contractors for CMS have so far failed to pay? That’s the question one lab CEO is asking. Both the commercial payers and the CMS contractors are […]
One Lab’s Revenue Loss Due to CMS’ Slow Process
Some private payers continue to reimburse for lab’s molecular tests, while CMS pays nothing
- By Joseph Burns
- > From the Volume XX No. 5 - April 15, 2013 Issue
- Tags: american clinical lab, american clinical laboratory, clinical lab, clinical lab fee schedule, clinical laboratories, Clinical Laboratory, clinical labs, cpt, cpt code, cpt code 81225, cpt code 81227, Diagnostic tests, lab ceo, lab executive, lab industry, lab leader, lab test, laboratories, laboratory association, laboratory companies, laboratory executive, Medicare, molecular assay, molecular assays, molecular diagnostic, molecular diagnostic test, molecular diagnostic tests, molecular tests, pathologists, Pathology group, private payer, test menu
